CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

A Cancer Drug that Impacted My Life for SLL

April 26th 2024, 5:00pm

Article

After reading a book about how Imbruvica was revolutionized for SLL and CLL, I now have a greater appreciation for the drugs I receive.

Diagnostic Tests in CLL

April 25th 2024, 12:12am

Video

Dr Linhares gives a comprehensive overview of tests a patient might expect to undergo at the time of diagnosis and why they are important.

Understanding a CLL Diagnosis

April 25th 2024, 12:07am

Video

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, introduce themselves and give an overview of chronic lymphocytic leukemia (CLL), highlighting symptoms and patient presentation.

FDA Approves Breyanzi for Relapsed/Refractory CLL/SLL

March 15th 2024, 1:42pm

Article

Breyanzi has been approved by the FDA for some previously treated patients with CLL or SLL — marking the first CAR-T cell therapy approved for this patient population.

FDA Approves Easier-to-Swallow Imbruvica Formulation

February 29th 2024, 10:00pm

Article

An oral suspension formula of Imbruvica received the green light from the Food and Drug Administration to be used in all approved indications.

Drug Combos May Help Lower Blood Pressure in Patients Taking Imbruvica

February 6th 2024, 8:00pm

Article

Certain antihypertensive medications may lower blood pressure in patients with blood cancer being treated with Imbruvica or other BTK inhibitors.

Cord Blood-Derived Treatment Shows Promise in Blood Cancer

January 25th 2024, 8:00pm

Article

A CAR NK therapy made from cord blood showed promising responses in patients with relapsed or refractory B-cell malignancies.

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

January 22nd 2024, 2:02pm

Podcast

We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.

FDA Grants NX-5948 Fast Track Designation for R/R CLL, SLL

January 18th 2024, 2:00pm

Article

BTK degrader NX-5948 has been granted Fast Track designation by the FDA to treat some adults with relapsed or refractory chronic lymphocytic leukemia or relapsed or refractory small lymphocytic lymphoma.

Top CLL Stories of 2023

January 2nd 2024, 4:00pm

Article

The top stories on chronic lymphocytic leukemia from 2023 included topics like BTK inhibitors, minimal residual disease status and approaches to care for various stages of the disease.